AHCO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AHCO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, AdaptHealth's Enterprise Value is $3,502 Mil. AdaptHealth's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-602 Mil. Therefore, AdaptHealth's EV-to-EBIT for today is -5.81.
The historical rank and industry rank for AdaptHealth's EV-to-EBIT or its related term are showing as below:
During the past 7 years, the highest EV-to-EBIT of AdaptHealth was 61.69. The lowest was -877.21. And the median was 12.09.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. AdaptHealth's Enterprise Value for the quarter that ended in Mar. 2024 was $3,808 Mil. AdaptHealth's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-602 Mil. AdaptHealth's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -15.82%.
The historical data trend for AdaptHealth's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AdaptHealth Annual Data | ||||||||||||||||
Trend | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
EV-to-EBIT | Get a 7-Day Free Trial | 63.49 | -24.31 | 19.22 | 23.51 | -5.38 |
AdaptHealth Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
EV-to-EBIT | Get a 7-Day Free Trial | 21.57 | 21.15 | -10.83 | -5.38 | -6.32 |
For the Medical Devices subindustry, AdaptHealth's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, AdaptHealth's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where AdaptHealth's EV-to-EBIT falls into.
AdaptHealth's EV-to-EBIT for today is calculated as:
EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
= | 3501.657 | / | -602.428 | |
= | -5.81 |
AdaptHealth's current Enterprise Value is $3,502 Mil.
AdaptHealth's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-602 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AdaptHealth (NAS:AHCO) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.
AdaptHealth's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:
Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) | = | EBIT | / | Enterprise Value (Q: Mar. 2024 ) |
= | -602.428 | / | 3807.85745 | |
= | -15.82 % |
AdaptHealth's Enterprise Value for the quarter that ended in Mar. 2024 was $3,808 Mil.
AdaptHealth's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-602 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of AdaptHealth's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Williams David Solomon Iii | director | 6272 CONDON AVE, LOS ANGELES CA 90056 |
Skyknight Aero Holdings, Llc | director | C/O SKYKNIGHT CAPITAL, L.P., ONE LETTERMAN DR., BLDG. C, SUITE 3-950, SAN FRANCISCO CA 94129 |
Albert A. Prast | officer: Chief Technology Officer | 3325 BARTLETT BLVD., ORLANDO FL 32811 |
Jason A Clemens | officer: Chief Financial Officer | 220 WEST GERMANTOWN PIKE, SUITE 250, C/O ADAPTHEALTH LLC, PLYMOUTH MEETING PA 19462 |
Christine E. Archbold | officer: Chief Accounting Officer | FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SEL 8EZ |
Everest Hill Group Inc. | 10 percent owner | TROPIC ISLE BUILDING, P O BOX 3331, ROAD TOWN TORTOLA D8 VG 1110 |
Daniel Bunting | officer: COO - Branch Operations | 12200 N.W. AMBASSADOR DRIVE, SUITE 326, KANSAS CITY MO 64163 |
Shaw Rietkerk | officer: Chief Revenue Officer | C/O ADAPTHEALTH LLC, 220 WEST GERMANTOWN PIKE, SUITE 250, PLYMOUTH MEETING PA 19462 |
Christopher J Joyce | officer: General Counsel | C/O ALLIANCE ENTERTAINMENT CORP, 110 EAST 59TH STREET 18TH FLOOR, NEW YORK NY 10022 |
Skyknight Aero Holdings Ii, Llc | director | C/O SKYKNIGHT CAPITAL, L.P., ONE LETTERMAN DR., BLDG. C, SUITE 3-950, SAN FRANCISCO CA 94129 |
Skyknight Capital, L.p. | director | C/O SKYKNIGHT CAPITAL, ONE LETTERMAN DR., BLDG. C, SUITE 3-950, SAN FRANCISCO CA 94129 |
Skyknight Capital Fund Ii, L.p. | director | ONE LETTERMAN DRIVE, BUILDING C, SUITE 3-950, SAN FRANCISCO CA 94129 |
Stephen P Griggs | director, officer: Co-Chief Executive Officer | 1360 PLACE VENDOME, WINTER PARK FL 32789 |
Gregory Belinfanti | director | 7500 RIALTO BLVD, BLDG TWO, STE 100, AUSTIN TX 78735 |
Frank Mullen | officer: Chief Accounting Officer | 4553 GLENCOE AVENUE, SUITE 300, LOS ANGELES CA 90292 |
From GuruFocus
By PRNewswire • 11-30-2023
By PRNewswire • 12-10-2023
By Business Wire • 11-17-2023
By PRNewswire • 12-14-2023
By Business Wire • 12-07-2023
By PRNewswire • 11-28-2023
By Business Wire • 12-29-2023
By PRNewswire • 12-11-2023
By PRNewswire • 12-18-2023
By PRNewswire • 11-20-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.